<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00767962</url>
  </required_header>
  <id_info>
    <org_study_id>2007-A00342-51</org_study_id>
    <nct_id>NCT00767962</nct_id>
  </id_info>
  <brief_title>A Prospective Randomised Study of Efficacy, Safety and Costs of Talc Pleurodesis Under Medical Thoracoscopy and Pleurodesis Under Video-assisted Thoracoscopy Surgery for Recurrent Primary Spontaneous Pneumothorax</brief_title>
  <official_title>A Prospective Randomised Study of Efficacy, Safety and Costs of Talc Pleurodesis Under Medical Thoracoscopy and Pleurodesis Under Video-assisted Thoracoscopy Surgery for Recurrent Primary Spontaneous Pneumothorax</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of recurrent primary spontaneous pneumothorax remains controversial and many&#xD;
      therapeutic options exist. The aim of this study is to compare pleural symphysis by talc&#xD;
      poudrage during medical thoracoscopy and surgical management combining pleural abrasion and&#xD;
      blebs or bullae resection for treatment of recurrent primary spontaneous pneumothorax.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment of recurrent primary spontaneous pneumothorax remains controversial and many&#xD;
      therapeutic options exist. What is the best technical option : treatment of the lung and the&#xD;
      parietal pleura or treatment of the pleura with pleural symphysis ? Talc pleurodesis&#xD;
      performed during medical thoracoscopy and resection of blebs or bullae associated with&#xD;
      pleural abrasion during surgical thoracoscopy (or video-assisted thoracic surgery) are the&#xD;
      most usual methods. These two procedures have never been compared in a prospective trial. The&#xD;
      aim of this study is to compare pleural symphysis by talc poudrage during medical&#xD;
      thoracoscopy and surgical management combining pleural abrasion and blebs or bullae resection&#xD;
      for treatment of recurrent primary spontaneous pneumothorax.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to show the non-inferiority of talc pleurodesis under medical thoracoscopy versus pleurodesis under video-assisted thoracoscopy surgery for recurrent primary spontaneous pneumothorax</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Pneumothorax</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>talc pleurodesis under medical thoracoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>pleurodesis under video-assisted thoracoscopy surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>talc pleurodesis under medical thoracoscopy</intervention_name>
    <description>talc pleurodesis under medical thoracoscopy for recurrent primary spontaneous pneumothorax</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pleurodesis under video-assisted thoracoscopy surgery</intervention_name>
    <description>pleurodesis under video-assisted thoracoscopy surgery for recurrent primary spontaneous pneumothorax</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects :both sexes, who the age is included between 18 years and 55 years;&#xD;
&#xD;
          -  Presenting a recurrence homolaterale or controlaterale of a primary spontaneous&#xD;
             pneumothorax;&#xD;
&#xD;
          -  Presenting a bilateral primary spontaneous pneumothorax&#xD;
&#xD;
          -  Presenting a failure of a manual inhalation for a primary spontaneous pneumothorax;&#xD;
&#xD;
          -  Presenting a persistent superior bullage at 48 am after a thoracic drainage for a&#xD;
             spontaneous pneumothorax&#xD;
&#xD;
          -  Presenting a persistent superior bullage at 48 am after a thoracic drainage for a&#xD;
             primary spontaneous pneumothorax;&#xD;
&#xD;
          -  Presenting a persistent superior unsticking at 48 am after a thoracic drainage for a&#xD;
             primary spontaneous pneumothorax;&#xD;
&#xD;
          -  Presenting a first episode of pneumothorax spontaneous primary with risk factor of&#xD;
             recurrence&#xD;
&#xD;
          -  The unsticking must be complete or important (superior to 3 cms between the summit of&#xD;
             the lung and the summit of the thoracic cavity or superior to 2 cms with regard to the&#xD;
             side thoracic wall);&#xD;
&#xD;
          -  Benefiting from a national insurance scheme;&#xD;
&#xD;
          -  Agreeing to participate in the study, and having read, included and signed the note of&#xD;
             information intended in patients.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects:Presenting a traumatic pneumothorax; Presenting a pneumothorax iatrogÃƒÂ¨ne;&#xD;
             Presenting a secondary spontaneous pneumothorax ( underlying pleuro-lung pathology);&#xD;
             Presenting bubbles of emphysema of size(cutting) superior to 5 cms; presenting a&#xD;
             pneumothorax catamenial;Presenting one of the following concomitant severe pathologies&#xD;
             dissuading a general anesthetic or any symphysant gesture(movement): cardiac&#xD;
             insufficiency&#xD;
&#xD;
          -  Pregnant or breast-feeding Woman;&#xD;
&#xD;
          -  presenting neurological disorders or psychiatric forbidding the understanding of the&#xD;
             essay;&#xD;
&#xD;
          -  Who the follow-up is impossible;&#xD;
&#xD;
          -  Deprived of freedom following a court or administrative order;&#xD;
&#xD;
          -  Not having signed the enlightened assent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne FRATICELLI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique des Hopitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'Oncologie Thoracique- HÃ´pital Sainte Marguerite</name>
      <address>
        <city>Marseille</city>
        <zip>13274</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>October 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2008</study_first_posted>
  <last_update_submitted>August 21, 2015</last_update_submitted>
  <last_update_submitted_qc>August 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recurrent primary spontaneous pneumothorax</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumothorax</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

